Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults

被引:31
作者
de Tute, R
Yuille, M
Catovsky, D
Houlston, RS
Hillmen, P
Rawstron, AC
机构
[1] Leeds Teaching Hosp, NHS Trust, HMDS, Leeds, W Yorkshire, England
[2] Rosalind Franklin Ctr Genom Res, Cambridge, England
[3] Canc Res Inst, Sect Canc Genet, Surrey, England
基金
英国医学研究理事会;
关键词
D O I
10.1038/sj.leu.2404116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:728 / 729
页数:3
相关论文
共 8 条
[1]   Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly [J].
Ghia, P ;
Prato, G ;
Scielzo, C ;
Stella, S ;
Geuna, M ;
Guida, G ;
Caligaris-Cappio, F .
BLOOD, 2004, 103 (06) :2337-2342
[2]   Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database [J].
Goldin, LR ;
Pfeiffer, RM ;
Li, XJ ;
Hemminki, K .
BLOOD, 2004, 104 (06) :1850-1854
[3]   B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia [J].
Marti, GE ;
Carter, P ;
Abbasi, F ;
Washington, GC ;
Jain, N ;
Zenger, VE ;
Ishibe, N ;
Goldin, L ;
Fontaine, L ;
Weissman, N ;
Sgambati, M ;
Fauget, G ;
Bertin, P ;
Vogt, RF ;
Slade, B ;
Noguchi, PD ;
Stetler-Stevenson, MA ;
Caporaso, N .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2003, 52B (01) :1-12
[4]   Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts [J].
Rawstron, AC ;
Green, MJ ;
Kuzmicki, A ;
Kennedy, B ;
Fenton, JAL ;
Evans, PAS ;
O'Connor, SJM ;
Richards, SJ ;
Morgan, GJ ;
Jack, AS ;
Hillmen, P .
BLOOD, 2002, 100 (02) :635-639
[5]   Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion [J].
Rawstron, AC ;
Yuille, MR ;
Fuller, J ;
Cullen, M ;
Kennedy, B ;
Richards, SJ ;
Jack, AS ;
Matutes, E ;
Catovsky, D ;
Hillmen, P ;
Houlston, RS .
BLOOD, 2002, 100 (07) :2289-2291
[6]   Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy [J].
Rawstron, AC ;
Kennedy, B ;
Evans, PAS ;
Davies, FE ;
Richards, SJ ;
Haynes, AP ;
Russell, NH ;
Hale, G ;
Morgan, GJ ;
Jack, AS ;
Hillmen, P .
BLOOD, 2001, 98 (01) :29-35
[7]  
Sakai A, 2000, BLOOD, V95, P1413
[8]   Anticipation in familial chronic lymphocytic leukaemia [J].
Yuille, MR ;
Houlston, RS ;
Catovsky, D .
LEUKEMIA, 1998, 12 (11) :1696-1698